News | RIVM

Chromium-6 from medical implants not harmful to health

Chromium-6 from medical implants, such as hip or knee implants, does not result in severe health damage.

Ten years of Tick Radar 80,000 tick bite reports; chances of being bitten highest in Drenthe

After recording 80,000 tick bites in 10 years via Tekenradar.nl, we now know that you are most likely to be bitten by a tick in Drenthe. Quickly removing the tick halves the chance of contracting Lyme disease.

Long-term symptoms more common after Lyme disease

More than a quarter of people with Lyme disease continue to have long-term symptoms that lead to limitations in daily life even after treatment.

Spread of tick-borne encephalitis virus in the Netherlands

Every year about 1.5 million ticks bite someone in the Netherlands, especially between March and October. Most people will not get sick of that.

Tick found in Drenthe is a Hyalomma tick

RIVM has investigated the so-called giant tick that was found in Odoorn in the province of Drenthe on 13 July. It is a Hyalomma marginatum female.

If you have found a tick bite, check for others!

One in five people who report having been bitten by a tick on Tekenrader.nl report that they have more than one tick bite. If you have found one tick bite, check for others!

Possible health risks due to exposure to chromium-6 at tROM project Tilburg

Research by RIVM shows that the participants in the so-called tROM project, their supervisors and other people involved may have been exposed to chromium-6.

Protection of Defence personnel against health risks of chromium-6 was inadequate

From 1984-2006, employees of the Dutch Ministry of Defence were exposed to chromium-6 during maintenance work.

Lyme disease cases have quadrupled

According to a survey by RIVM , 27,000 people were infected with Lyme disease in 2017. In 2014, the last time RIVM reported on the incidence of tick-borne disease, this number was 25,000.

Lyme disease costs EUR 20 million annually

The societal costs of Lyme disease have been determined for the Netherlands for the first time. The disease appears to cost nearly EUR 20 million each year.